1 Min Read
May 21 (Reuters) - Dova Pharmaceuticals Inc:
* DOVA PHARMACEUTICALS ANNOUNCES U.S. FDA APPROVAL OF DOPTELET® (AVATROMBOPAG)
* DOVA PHARMACEUTICALS INC - POSITIONED TO LAUNCH DOPTELET IN JUNE Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.